Biosimilar naming in the US, the debate continues

Posted 20/11/2015

The United States Pharmacopeial Convention (USP) has called on the US Food and Drug Administration (FDA) to reconsider its draft guidance Nonproprietary Nami...

Safety monitoring of drug interchangeability Generics/Research | Posted 20/11/2015
Biosimilar naming conventions around the world Biosimilars/Research | Posted 20/11/2015
US politicians form Affordable Drug Pricing Tas... Generics/General | Posted 20/11/2015
Positive phase III results for Samsung Bioepis... Biosimilars/Research | Posted 20/11/2015
Celltrion submits rituximab biosimilar applicat... Biosimilars/News | Posted 20/11/2015
Mylan will not be acquiring Perrigo Pharma News | Posted 20/11/2015
World Generic Medicines Congress Europe 2016 Conferences | Posted 20/11/2015
Biologicals patent expiries Biosimilars/General | Posted 13/11/2015
Biosimilars and interchangeability Biosimilars/Research | Posted 13/11/2015
FDA evaluation of residual solvents in generics Generics/Research | Posted 13/11/2015
Economic considerations for rheumatoid arthriti... Biosimilars/Research | Posted 13/11/2015
Pfizer cuts some biosimilars after Hospira deal Pharma News | Posted 13/11/2015
Tentative FDA approval for chemotherapy generic Generics/News | Posted 13/11/2015
Formycon starts phase III trial for ranibizumab... Biosimilars/News | Posted 13/11/2015
Prescribing generics for chronic musculoskeleta... Generics/Research | Posted 06/11/2015
Non-originator low molecular weight heparins: g... Biosimilars/Research | Posted 06/11/2015
Senator calls for FTC to investigate drugmakers... Policies & Legislation | Posted 06/11/2015
Positive phase I results for adalimumab biosimilar Biosimilars/Research | Posted 06/11/2015
FDA making progress with ANDA backlog Generics/General | Posted 06/11/2015
Sandoz launches authorized fluvastatin generic... Generics/News | Posted 06/11/2015
Biosimilar naming and AE reporting Biosimilars/Research | Posted 30/10/2015
FDA evaluation of impurities in generics Generics/Research | Posted 30/10/2015
Biosimilars of ranibizumab Biosimilars/General | Posted 30/10/2015
Boehringer Ingelheim stops biosimilar rituximab... Biosimilars/News | Posted 30/10/2015
Rituximab biosimilar claimed similar pharmacoki... Biosimilars/Research | Posted 30/10/2015
Teva launches enlarged prostate generic in the US Generics/News | Posted 30/10/2015
Biosimilars use in Italy increasing Biosimilars/Research | Posted 23/10/2015
Call for compulsory license for biosimilar tras... Biosimilars/General | Posted 23/10/2015
FDA evaluation of excipients in generics Generics/Research | Posted 23/10/2015
Biosimilars substitution bill becomes law in Ca... Policies & Legislation | Posted 23/10/2015
Candidate infliximab biosimilar SB2 equivalent... Biosimilars/Research | Posted 23/10/2015
Brand-name drugmakers gain extra days of patent... Generics/General | Posted 23/10/2015
Insulin glargine biosimilar in US delayed until... Biosimilars/News | Posted 23/10/2015
ADHD generic receives US FDA approval Generics/News | Posted 23/10/2015
Australia’s DoH seeks feedback on biosimilars a... Biosimilars/General | Posted 16/10/2015
Pharmacovigilance compliance for biocomparables... Biosimilars/Research | Posted 16/10/2015
Effectiveness and cost-effectiveness of osteopo... Generics/Research | Posted 16/10/2015
Positive phase I results for pegfilgrastim bios... Biosimilars/Research | Posted 16/10/2015
Baxalta and Momenta start phase III trial for a... Biosimilars/News | Posted 16/10/2015
Teva acquires Mexican drugmaker Rimsa Pharma News | Posted 16/10/2015
Sanofi launches authorized leflunomide generic... Generics/News | Posted 16/10/2015
European paediatricians advocate biosimilar tri... Biosimilars/General | Posted 09/10/2015
Answers to questions about anti-TNF biosimilars Biosimilars/Research | Posted 09/10/2015

Generics News Research General


Biosimilars News Research General